We are live on ! Find out more
GAI

General American Investors Portfolio holdings

AUM $1.69B
1-Year Est. Return 40.94%
This Fund
S&P 500
This Quarter Est. Return
+15.32%
1 Year Est. Return
+40.94%
3 Year Est. Return
+128.91%
5 Year Est. Return
+178.43%
10 Year Est. Return
+618.93%
AUM
$1.01B
AUM Growth
+$55.8M
Cap. Flow
-$69.9M
Cap. Flow %
-6.94%
Top 10 Hldgs %
38.41%
Holding
70
New
2
Increased
3
Reduced
19
Closed
4

Top Buys

Rank Stock Value
1
TGT icon
Target
TGT
+$12.9M
2
MSGS icon
Madison Square Garden
MSGS
+$5.84M
3
CRBP icon
Corbus Pharmaceuticals
CRBP
+$4.1M
4
M icon
Macy's
M
+$1.89M
5
IDCC icon
InterDigital
IDCC
+$695K

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$14.7M
2
AON icon
Aon
AON
+$13.7M
3
TJX icon
TJX Companies
TJX
+$12M
4
MSFT icon
Microsoft
MSFT
+$10.9M
5
CELG
Celgene Corp
CELG
+$8.75M

Sector Composition

Rank Sector Weight
1 Financials 20.33%
2 Technology 19.5%
3 Consumer Discretionary 11.74%
4 Industrials 10.92%
5 Communication Services 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOD icon
51
Vodafone
VOD
$36.4B
$6.23M 0.62%
342,900
ESV
52
DELISTED
Ensco Rowan plc
ESV
$5.21M 0.52%
331,250
CELG
53
DELISTED
Celgene Corp
CELG
$5.19M 0.51%
55,000
-100,000
-65% -$8.75M
PETX
54
DELISTED
Aratana Therapeutics, Inc.
PETX
$5.1M 0.51%
1,416,926
-182,439
-11% -$791K
MNDT
55
DELISTED
Mandiant, Inc. Common Stock
MNDT
$4.93M 0.49%
293,794
PXD
56
DELISTED
Pioneer Natural Resource Co.
PXD
$4.65M 0.46%
30,556
KIN
57
DELISTED
Kindred Biosciences, Inc.
KIN
$4.12M 0.41%
449,574
CRBP icon
58
Corbus Pharmaceuticals
CRBP
$177M
$3.87M 0.38%
+18,580
New +$4.1M
ITCI
59
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.65M 0.36%
299,942
VBIV
60
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$3.3M 0.33%
58,815
RSP icon
61
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$2.94M 0.29%
28,111
ADX icon
62
Adams Diversified Equity Fund
ADX
$3.21B
$2.73M 0.27%
188,819
RVT icon
63
Royce Value Trust
RVT
$2.29B
$2.72M 0.27%
197,358
PRTK
64
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2.49M 0.25%
464,985
APDNW
65
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
$5K ﹤0.01%
281,409
MSFT icon
66
PUT
Microsoft
MSFT
$3.76T
-1,500
Closed -$728K
SBGI icon
67
Sinclair Inc
SBGI
$995M
-197,196
Closed -$5.19M
TJX icon
68
PUT
TJX Companies
TJX
$175B
-3,800
Closed -$1.52M
WMT icon
69
Walmart Inc
WMT
$897B
-473,625
Closed -$14.7M

Similar funds

General American Investors's Q1 2019 Portfolio in Review

As of Q1 2019, General American Investors held 70 positions worth $1.01B, up 5.9% from $952M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

General American Investors withdrew a net $69.9M in Q1 2019, closing 4 positions and reducing 19 holdings. Its most notable exit was Walmart Inc, an estimated $14.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, General American Investors opened a new position in Target worth $14.2M.

  • General American Investors's largest Q1 2019 buy was Target: 176,800 shares worth $14.2M.
  • General American Investors added most to Madison Square Garden in Q1 2019, an estimated $5.84M increase.
  • General American Investors's biggest Q1 2019 reduction was Aon, cutting an estimated $13.7M.
  • General American Investors fully exited Walmart Inc in Q1 2019, selling an estimated $14.7M.
  • General American Investors's ten largest holdings make up 38% of its $1.01B portfolio in Q1 2019.
  • General American Investors opened 2 new positions and closed 4 in Q1 2019.
  • General American Investors's portfolio value rose 5.9% quarter-over-quarter to $1.01B.

Based on General American Investors's 13F filing for Q1 2019, filed 1 May 2019.